Study guide

17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation

Key Takeaways Explain This Topic AI

Inhalational induction with Sevoflurane (titrated up to 8% in 70/30 N₂O/O₂ or 100% O₂) is the gold standard for needle-phobic, cooperative children without aspiration risks; IV induction with Propofol requires a higher pediatric dose (2.5 to 3.5 mg/kg) due to an expanded central distribution volume and rapid hepatic clearance.

Endotracheal tube (ETT) internal diameter (ID) sizing is calculated using standard formulas: Cole uncuffed ID = (Age / 4) + 4; Khine/Motoyama cuffed ID = (Age / 4) + 3.5; depth of insertion at the lip is estimated by (Age / 2) + 12 cm or 3 × ETT ID.

A mandatory ETT leak test must demonstrate an audible air leak at 15 to 25 cmH₂O; a leak at <10-15 cmH₂O indicates inadequate seal and aspiration risk, whereas absence of a leak at >25 cmH₂O risks ischemic mucosal injury over the cricoid ring, post-extubation croup, and subglottic stenosis.

Intraoperative fluid management uses balanced isotonic crystalloids (Lactated Ringer's or Plasma-Lyte) guided by the 4-2-1 rule plus NPO deficit replacement (50% in hour 1, 25% in hour 2, 25% in hour 3); routine dextrose is avoided except in neonates, premature infants, SGA infants, or prolonged cases (maintaining blood glucose 60 to 150 mg/dL).

Maximum Allowable Blood Loss (MABL) is determined from age-adjusted Estimated Blood Volume (Preterm: 90-100 mL/kg, Term neonate: 80-90 mL/kg, Infant: 75-80 mL/kg, Child: 70-75 mL/kg) via MABL = EBV × [(Hct_initial - Hct_target) / Hct_initial]; Emergence Agitation (EA) is prevented with Propofol 1 mg/kg at emergence, Dexmedetomidine 0.3-0.5 mcg/kg IV, and regional/caudal blockade.

Last updated: August 2026

17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation

Administering anesthesia to pediatric patients demands flawless execution of airway management, meticulous fluid balance calculations, and aggressive strategies to mitigate post-anesthesia emergence delirium. Mastery of age-specific tube formulas, hemodynamic monitoring, and fluid homeostasis is foundational to safe pediatric practice.

1. Pediatric Induction Techniques

Induction strategies are tailored to the child's developmental age, fasting status, anxiety level, and pre-existing medical conditions. +---------------------------------------------------------------------------------------------------------+

  • | PEDIATRIC INDUCTION STRATEGIES & DOSING |
  • +---------------------+-------------------------------+---------------------------------------------------+
  • | Technique | Drug Regimen | Clinical Indications & Critical Nuances |
  • +---------------------+-------------------------------+---------------------------------------------------+
  • | **Inhalational** | • Sevoflurane (up to 8%) | • Gold standard for needle-phobic, cooperative |
  • | **Induction** | • 70% N₂O / 30% O₂ or 100% O₂ | children without full stomach / reflux risks |
  • | | • High fresh gas flow (6-8 LPM| • Maintain quiet OR; do not stimulate in Stage II |
  • +---------------------+-------------------------------+---------------------------------------------------+
  • | **Intravenous** | • Propofol **2.5 - 3.5 mg/kg**| • Rapid, reliable onset with pre-existing IV |
  • | **Induction** | • Fentanyl **1 - 2 mcg/kg** | • Requires higher dose in infants due to expanded |
  • | | • Lidocaine 0.5 - 1 mg/kg | central compartment and rapid glucuronidation |
  • +---------------------+-------------------------------+---------------------------------------------------+
  • | **Intramuscular** | • Ketamine **3 - 5 mg/kg** IM | • Uncooperative, combative, or autistic child |
  • | **"Dart" Induction**| • Glycopyrrolate 0.01 mg/kg IM| without IV access; onset 3 - 5 minutes |
  • | | • Midazolam 0.1 mg/kg IM | • Glycopyrrolate prevents severe hypersalivation |
  • +---------------------+-------------------------------+---------------------------------------------------+
  • | **Rapid Sequence** | • Propofol 3 mg/kg + | • Full stomach, trauma, acute abdomen, bowel |
  • | **Induction (RSI)** | Succinylcholine 2 mg/kg IV | obstruction; cricoid pressure controversial; |
  • | | (or Rocuronium 1.2 mg/kg IV)| pre-treat with Atropine 0.02 mg/kg IV |
  • +---------------------+-------------------------------+---------------------------------------------------+
  • Inhalational Induction Nuances & Stage II Management

Stepped vs. High-Dose Single-Breath Technique: Inhalational induction can be performed by stepping up Sevoflurane by 1 % − 2 % 1\% - 2\% 1% − 2% every few breaths or priming the circuit with 8 % 8\% 8% Sevoflurane in 70 % N 2 O / 30 % O 2 70\% \text{ N}_2\text{O} / 30\% \text{ O}_2 70% N 2 ​ O /30% O 2 ​ for a rapid single-breath induction. Sevoflurane is the volatile agent of choice because it is non-pungent, non-irritating to the tracheobronchial tree, and produces rapid loss of consciousness without airway secretions.

Navigating Stage II Anesthesia: As the child transitions from consciousness to surgical anesthesia, they pass through Stage II (the excitement stage) , characterized by irregular breathing, breath-holding, conjugate/dysconjugate roving eye movements, hyperreflexia, and heightened laryngeal sensitivity. No airway manipulation, IV starts, or patient repositioning should occur during Stage II , as tactile or painful stimulation during this light plane readily triggers catastrophic laryngospasm or severe bronchospasm .

2. Endotracheal Tube Sizing, Depth & Leak Testing

Modern pediatric anesthesia utilizes micro-cuffed endotracheal tubes (with ultra-thin polyurethane cuffs) down to full-term neonates. Cuffed tubes provide a reliable seal at low mucosal pressures ( < 20 cmH 2 O <20 \text{ cmH}_2\text{O} < 20 cmH 2 ​ O ), reduce tube exchange rates, ensure accurate end-tidal gas and spirometry monitoring, and decrease theater pollution. +---------------------------------------------------------------------------------------------------------+

  • | ENDOTRACHEAL TUBE SIZING FORMULAS |
  • +-------------------------+-----------------------------------+-------------------------------------------+
  • | Tube Type | Calculation Formula | Example for 4-Year-Old Child |
  • +-------------------------+-----------------------------------+-------------------------------------------+

| **Uncuffed ETT ID** | **$\text{ID} = \frac{\text{Age}}{4} + 4$** | $\frac{4}{4} + 4 = \mathbf{5.0\text{ mm ID}}$ |

  • | (Cole Formula) | | |
  • +-------------------------+-----------------------------------+-------------------------------------------+

| **Cuffed ETT ID** | **$\text{ID} = \frac{\text{Age}}{4} + 3.5$** | $\frac{4}{4} + 3.5 = \mathbf{4.5\text{ mm ID}}$ |

  • | (Khine / Motoyama) | | |
  • +-------------------------+-----------------------------------+-------------------------------------------+

| **Modified Duracher** | **$\text{ID} = \frac{\text{Age}}{4} + 3.0$** | $\frac{4}{4} + 3.0 = \mathbf{4.0\text{ mm ID}}$ (infants) |

  • | (Infants <2 years) | | |
  • +-------------------------+-----------------------------------+-------------------------------------------+

| **Depth of Insertion** | **$\text{Depth (cm)} = \frac{\text{Age}}{2} + 12$** | $\frac{4}{2} + 12 = \mathbf{14\text{ cm}}$ at the lip |

| (Alveolar Ridge / Lip) | **$\text{Depth (cm)} = 3 \times \text{ETT ID}$** | $3 \times 4.5 = \mathbf{13.5\text{ cm}}$ at the lip |

+-------------------------+-----------------------------------+-------------------------------------------+ +---------------------------------------------------------------------------------------------------------+

  • | AGE-SPECIFIC TUBE SELECTION GUIDELINE |
  • +-----------------------------+-----------------------------+----------------------+----------------------+
  • | Age Group | Uncuffed ETT (mm ID) | Cuffed ETT (mm ID) | Insertion Depth (cm) |
  • +-----------------------------+-----------------------------+----------------------+----------------------+
  • | **Premature (<1000 g)** | 2.5 | Not recommended | 6 - 7 cm |
  • | **Premature (1000 - 2500 g)**| 3.0 | 2.5 | 7 - 8 cm |
  • | **Full-Term Neonate** | 3.0 - 3.5 | 3.0 | 9 - 10 cm |
  • | **Infant (1 - 12 months)** | 3.5 - 4.0 | 3.0 - 3.5 | 10 - 12 cm |
  • | **Child 1 - 2 years** | 4.0 - 4.5 | 3.5 - 4.0 | 12 - 13 cm |
  • | **Child >2 years** | $(\text{Age}/4) + 4$ | $(\text{Age}/4) + 3.5$| $(\text{Age}/2) + 12$|
  • +-----------------------------+-----------------------------+----------------------+----------------------+
  • The Mandatory Endotracheal Tube Leak Test

Following intubation, an objective cuff leak test must be performed to ensure mucosal capillary perfusion is preserved:

Connect breathing circuit, close the Adjustable Pressure Limiting (APL) valve, and place a stethoscope over the anterior laryngeal/tracheal cartilage.

Manually inflate the circuit reservoir bag until an audible air escape (leak) is auscultated at the mouth.

Ideal Leak Threshold: An audible leak should occur at 15 − 25 cmH 2 O 15 - 25 \text{ cmH}_2\text{O} 15 − 25 cmH 2 ​ O of peak airway pressure.

Leak < 10 − 15 cmH 2 O <10 - 15 \text{ cmH}_2\text{O} < 10 − 15 cmH 2 ​ O : Inadequate seal. Results in hypoventilation, loss of positive end-expiratory pressure (PEEP), inaccurate spirometry, and aspiration of gastric contents. Inflate cuff gently with minimal air ( < 20 cmH 2 O <20 \text{ cmH}_2\text{O} < 20 cmH 2 ​ O cuff pressure) or replace with 0.5 mm 0.5 \text{ mm} 0.5 mm larger ETT.

No Leak at > 25 cmH 2 O >25 \text{ cmH}_2\text{O} > 25 cmH 2 ​ O : Tube is too tight. Capillary perfusion pressure of the subglottic cricoid mucosa is approximately 25 − 30 mmHg 25 - 30 \text{ mmHg} 25 − 30 mmHg ( 30 − 35 cmH 2 O 30 - 35 \text{ cmH}_2\text{O} 30 − 35 cmH 2 ​ O ). Prolonged pressure exceeding this threshold causes circumferential mucosal ischemia, mucosal ulceration, post-extubation croup (stridor), and permanent subglottic cicatricial stenosis. Downsize the ETT by 0.5 mm 0.5 \text{ mm} 0.5 mm ID immediately.

3. Intraoperative Fluid Management & Glucose Regulation

Pediatric fluid management has evolved dramatically over the past two decades, transitioning away from routine hypotonic dextrose solutions toward balanced isotonic crystalloids.

The Holliday-Segar 4-2-1 Maintenance Rule

Maintenance hourly fluid requirements are calculated based on weight brackets: +---------------------------------------------------------------------------------------------------------+

  • | THE 4-2-1 HOURLY MAINTENANCE FLUID RULE |
  • +------------------------------------+--------------------------------------------------------------------+
  • | Weight Category | Hourly Fluid Rate Calculation |
  • +------------------------------------+--------------------------------------------------------------------+
  • | **First 10 kg (1 - 10 kg)** | • **4 mL/kg/hr** |
  • +------------------------------------+--------------------------------------------------------------------+
  • | **Second 10 kg (11 - 20 kg)** | • **40 mL/hr + 2 mL/kg/hr** for every kg between 11 and 20 kg |
  • +------------------------------------+--------------------------------------------------------------------+
  • | **Each kg Above 20 kg (>20 kg)** | • **60 mL/hr + 1 mL/kg/hr** for every kg above 20 kg |
  • | | • *Quick shortcut for >20 kg:* **Weight in kg + 40 = mL/hr** |
  • +------------------------------------+--------------------------------------------------------------------+

Calculation of NPO Deficit & Intraoperative Replacement Total NPO Deficit = Hourly Maintenance Rate × Hours Fasting (NPO) \text{Total NPO Deficit} = \text{Hourly Maintenance Rate} \times \text{Hours Fasting (NPO)} Total NPO Deficit = Hourly Maintenance Rate × Hours Fasting (NPO)

Intraoperative Replacement Schedule:

  • Hour 1 of Surgery: 50 % 50\% 50% of NPO Deficit + + + Hourly Maintenance + + + Surgical Third-Space Loss
  • Hour 2 of Surgery: 25 % 25\% 25% of NPO Deficit + + + Hourly Maintenance + + + Surgical Third-Space Loss
  • Hour 3 of Surgery: 25 % 25\% 25% of NPO Deficit + + + Hourly Maintenance + + + Surgical Third-Space Loss

Surgical Tissue Trauma / Third-Space Losses:

  • Mild trauma (e.g., hernia repair, strabismus): 1 − 2 mL/kg/hr 1 - 2 \text{ mL/kg/hr} 1 − 2 mL/kg/hr
  • Moderate trauma (e.g., open appendectomy, tonsillectomy): 3 − 5 mL/kg/hr 3 - 5 \text{ mL/kg/hr} 3 − 5 mL/kg/hr

Severe trauma (e.g., major bowel resection, thoracotomy): 6 − 10 mL/kg/hr 6 - 10 \text{ mL/kg/hr} 6 − 10 mL/kg/hr

Fluid Selection: Isotonic vs. Hypotonic & Dextrose Indications

Avoid Hypotonic Crystalloids: Historical administration of hypotonic fluids (e.g., D 5 0.2 % NaCl D_5 0.2\% \text{ NaCl} D 5 ​ 0.2% NaCl ) combined with stress-induced non-osmotic Anti-Diuretic Hormone (ADH) secretion led to disastrous hospital-acquired acute hyponatremic encephalopathy, cerebral edema, herniation, and death . Standard perioperative maintenance should always utilize balanced isotonic crystalloids (Lactated Ringer's, Plasma-Lyte, Normosol-R, or 0.9 % 0.9\% 0.9% Normal Saline).

Indications for Dextrose ( D 5 W D_5W D 5 ​ W in Balanced Isotonic Solution):

Neonates and premature infants ( < 1 <1 < 1 month of age) with low hepatic glycogen stores and immature gluconeogenesis.

Small for Gestational Age (SGA) or low birth weight infants.

Children receiving preoperative total parenteral nutrition (TPN) (infusion must not be stopped abruptly; taper or match intraop dextrose).

Patients with known mitochondrial or glycogen storage diseases.

Target Blood Glucose: 60 − 150 mg/dL 60 - 150 \text{ mg/dL} 60 − 150 mg/dL . Avoid hyperglycemia ( > 180 − 200 mg/dL >180 - 200 \text{ mg/dL} > 180 − 200 mg/dL ), as it triggers hyperosmotic diuresis, electrolyte wasting, and exacerbates lactic acidosis and neuronal apoptosis during periods of cerebral ischemia.

4. Blood Volume & Maximum Allowable Blood Loss (MABL)

Accurate assessment of intraoperative blood loss requires knowledge of age-specific Estimated Blood Volume (EBV) and strict calculation of the transfusion threshold. +---------------------------------------------------------------------------------------------------------+

  • | ESTIMATED BLOOD VOLUME (EBV) BY AGE GROUP |
  • +------------------------------------+--------------------------------------------------------------------+
  • | Age Group | Estimated Blood Volume (EBV) |
  • +------------------------------------+--------------------------------------------------------------------+
  • | **Premature Neonate** | **90 - 100 mL/kg** |
  • | **Full-Term Neonate (<30 days)** | **80 - 90 mL/kg** |
  • | **Infant (1 - 12 months)** | **75 - 80 mL/kg** |
  • | **Child (1 - 12 years)** | **70 - 75 mL/kg** |
  • | **Adult Male / Female** | **75 mL/kg (Male) / 65 mL/kg (Female)** |
  • +------------------------------------+--------------------------------------------------------------------+

MABL Mathematical Formula MABL = EBV × ( Hct starting − Hct target Hct starting ) \text{MABL} = \text{EBV} \times \left( \frac{\text{Hct}_{\text{starting}} - \text{Hct}_{\text{target}}}{\text{Hct}_{\text{starting}}} \right) MABL = EBV × ( Hct starting ​ Hct starting ​ − Hct target ​ ​ ) Total Blood Volume = Weight (kg) × EBV (mL/kg) \text{Total Blood Volume} = \text{Weight (kg)} \times \text{EBV (mL/kg)} Total Blood Volume = Weight (kg) × EBV (mL/kg)

Step-by-Step Clinical Calculation Example

Clinical Scenario: An 8-month-old infant weighing 8 kg 8 \text{ kg} 8 kg presents for craniofacial surgery. Preoperative hematocrit is 39 % 39\% 39% , and the acceptable target hematocrit is 28 % 28\% 28% .

Step 1: Calculate Total Blood Volume: TBV = 8 kg × 80 mL/kg = 640 mL \text{TBV} = 8 \text{ kg} \times 80 \text{ mL/kg} = 640 \text{ mL} TBV = 8 kg × 80 mL/kg = 640 mL

Step 2: Calculate MABL: MABL = 640 mL × ( 39 − 28 39 ) = 640 × ( 11 39 ) = 640 × 0.282 = 180.5 mL \text{MABL} = 640 \text{ mL} \times \left( \frac{39 - 28}{39} \right) = 640 \times \left( \frac{11}{39} \right) = 640 \times 0.282 = \mathbf{180.5\text{ mL}} MABL = 640 mL × ( 39 39 − 28 ​ ) = 640 × ( 39 11 ​ ) = 640 × 0.282 = 180.5 mL

Interpretation: The provider can replace blood loss up to 180 mL 180 \text{ mL} 180 mL with isotonic crystalloid ( 3 : 1 3:1 3 : 1 ratio) or 5 % 5\% 5% albumin ( 1 : 1 1:1 1 : 1 ratio). Blood loss beyond 180 mL 180 \text{ mL} 180 mL requires Packed Red Blood Cell (PRBC) transfusion.

PRBC Transfusion Volume Formula: Transfusion Volume (mL) = Weight (kg) × ( Desired Hct − Actual Hct ) × EBV Hct of PRBCs (approx 60%) \text{Transfusion Volume (mL)} = \frac{\text{Weight (kg)} \times (\text{Desired Hct} - \text{Actual Hct}) \times \text{EBV}}{\text{Hct of PRBCs (approx 60\%)}} Transfusion Volume (mL) = Hct of PRBCs (approx 60%) Weight (kg) × ( Desired Hct − Actual Hct ) × EBV ​ Or clinical rule of thumb: 10 − 15 mL/kg 10 - 15 \text{ mL/kg} 10 − 15 mL/kg PRBCs will raise hemoglobin by 2 − 3 g/dL 2 - 3 \text{ g/dL} 2 − 3 g/dL (Hct by 6 − 9 % 6 - 9\% 6 − 9% ).

5. Emergence Agitation (EA) & Delirium in Pediatrics

Emergence Agitation (EA) is a well-recognized clinical syndrome occurring in up to 30 % − 50 % 30\% - 50\% 30% − 50% of preschool-aged children undergoing general anesthesia with modern, low-solubility volatile anesthetics. +---------------------------------------------------------------------------------------------------------+

  • | EMERGENCE AGITATION (EA) CLINICAL PROFILE |
  • +---------------------+-----------------------------------------------------------------------------------+
  • | Characteristic | Clinical Presentation & Features |
  • +---------------------+-----------------------------------------------------------------------------------+
  • | **Definition** | • State of acute mental distress, non-purposeful thrashing, inconsolable crying, |
  • | | combative motor behavior, and lack of eye contact during early recovery (PACU). |
  • +---------------------+-----------------------------------------------------------------------------------+
  • | **Peak Age Group** | • **Toddlers & Preschool children (2 - 5 years of age)** |
  • +---------------------+-----------------------------------------------------------------------------------+
  • | **Primary Triggers**| • Rapid emergence from insoluble volatile agents (**Sevoflurane**, **Desflurane**) |
  • | | • High baseline child/parent anxiety; preschool developmental stage |
  • | | • Surgical procedures involving head/neck (ENT, tonsillectomy, strabismus) |
  • +---------------------+-----------------------------------------------------------------------------------+
  • | **Differential Dx** | • **Hypoxemia, Hypercapnia, Acidosis (Must rule out immediately!)** |
  • | | • Acute surgical pain, bladder distension, airway obstruction, tight casts |

+---------------------+-----------------------------------------------------------------------------------+ [PREVENTATIVE PHARMACOTHERAPY FOR EA]

  • [Multi-Targeted Prophylaxis Algorithm]
  • / | \
  • / | \
  • **Propofol Bolus** **Alpha-2 Agonists** **Regional Blocks**
  • 1.0 mg/kg IV • Dexmedetomidine • Caudal Epidural
  • at end of surgery 0.3 - 0.5 mcg/kg IV (0.125-0.2% Bupiv)
  • Smooths transition or 1 - 2 mcg/kg IN • Peripheral Blocks
  • from volatile • Clonidine 2 mcg/kg • Complete pain relief
  • Evidence-Based Prevention and Management Strategies

Propofol Bolus at Emergence: Administering Propofol 1.0 mg/kg 1.0 \text{ mg/kg} 1.0 mg/kg IV at the conclusion of surgery (as volatile anesthetic is discontinued) significantly reduces the incidence of emergence agitation without prolonging PACU discharge time.

Alpha-2 Receptor Agonists: Dexmedetomidine ( 0.3 − 0.5 mcg/kg 0.3 - 0.5 \text{ mcg/kg} 0.3 − 0.5 mcg/kg IV intraoperatively or 1.0 − 2.0 mcg/kg 1.0 - 2.0 \text{ mcg/kg} 1.0 − 2.0 mcg/kg intranasally preop) provides dose-dependent reduction in EA, decreases opioid consumption, and provides non-respiratory-depressant sedation.

Regional Anesthesia & Analgesia: Caudal epidural analgesia ( 1.0 mL/kg 1.0 \text{ mL/kg} 1.0 mL/kg of 0.125 % − 0.2 % 0.125\% - 0.2\% 0.125% − 0.2% Ropivacaine or Bupivacaine) or peripheral nerve blocks eliminate surgical nociception, the primary trigger for post-anesthetic agitation.

Non-Pharmacologic Measures: Maintain a quiet, dimly lit PACU environment; facilitate early parental presence at the bedside as soon as the patient establishes patent airway reflexes.

Loading diagram... Pediatric Fluid, MABL & Airway Management Algorithm